Top Stories
LTM, Uniphore join hands to build industry-specific AI solutions for enterprises Lupin secures USFDA approval for rare disease drug with $337 million opportunity IndiGo turmoil deepens: Another top executive quits after CEO exit Exide Industries Q4 Results: Net profit jumps 22% YoY, auto OEM growth drives strong earnings Godrej Properties Q4 Results: Net profit jumps 68% YoY; Guides for above 20% growth in FY27 BHEL Q4 FY26 Results: Net profit jumps over 150% YoY; EBITDA more than doubles on strong execution NCLAT rejects Vedanta’s plea against Adani Enterprises’ ₹14,535 crore bid for Jaypee Associates — Adani’s path to acquisition now clearer HUL rebounds 5% after post-results dip; 6% volume growth, FY27 outlook boost stock LTM, Uniphore join hands to build industry-specific AI solutions for enterprises Lupin secures USFDA approval for rare disease drug with $337 million opportunity IndiGo turmoil deepens: Another top executive quits after CEO exit Exide Industries Q4 Results: Net profit jumps 22% YoY, auto OEM growth drives strong earnings Godrej Properties Q4 Results: Net profit jumps 68% YoY; Guides for above 20% growth in FY27 BHEL Q4 FY26 Results: Net profit jumps over 150% YoY; EBITDA more than doubles on strong execution NCLAT rejects Vedanta’s plea against Adani Enterprises’ ₹14,535 crore bid for Jaypee Associates — Adani’s path to acquisition now clearer HUL rebounds 5% after post-results dip; 6% volume growth, FY27 outlook boost stock
TAG

# Emcure Pharmaceuticals

1 2